APA (7th ed.) Citation

MA, A., H, K., LJ, A., NS, S., & Y, M. (2017). Rafoxanide and Closantel Inhibit SPAK and OSR1 Kinases by Binding to a Highly Conserved Allosteric Site on Their C-terminal Domains. ChemMedChem, 12(9), 639. https://doi.org/10.1002/cmdc.201700077

Chicago Style (17th ed.) Citation

MA, AlAmri, Kadri H, Alderwick LJ, Simpkins NS, and Mehellou Y. "Rafoxanide and Closantel Inhibit SPAK and OSR1 Kinases by Binding to a Highly Conserved Allosteric Site on Their C-terminal Domains." ChemMedChem 12, no. 9 (2017): 639. https://doi.org/10.1002/cmdc.201700077.

MLA (9th ed.) Citation

MA, AlAmri, et al. "Rafoxanide and Closantel Inhibit SPAK and OSR1 Kinases by Binding to a Highly Conserved Allosteric Site on Their C-terminal Domains." ChemMedChem, vol. 12, no. 9, 2017, p. 639, https://doi.org/10.1002/cmdc.201700077.